Page last updated: 2024-11-12
zolpidem carboxylic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
zolpidem carboxylic acid: zolpidem metabolite; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 11966044 |
| SCHEMBL ID | 2309139 |
| MeSH ID | M0511684 |
Synonyms (16)
| Synonym |
|---|
| imidazo(1,2-a)pyridine, benzoic acid deriv. |
| zolpidem carboxylic acid |
| benzoic acid, 4-(3-(2-(dimethylamino)-2-oxoethyl)-6-methylimidazo(1,2-a)pyridin-2-yl)- |
| 109461-65-6 |
| ogv9r9660k , |
| unii-ogv9r9660k |
| sl 84.0589 |
| 4-[3-[2-(dimethylamino)-2-oxoethyl]-6-methylimidazo[1,2-a]pyridin-2-yl]benzoic acid |
| zolpidem phenyl-4-carboxylic acid |
| SCHEMBL2309139 |
| DTXSID50148941 |
| zolpidem-m carboxylic acid |
| BCP10204 |
| Q27285649 |
| A903989 |
| zolpidem phenyl-4-carboxylic acid (1 mg/ml in 1:1 acetonitrile:water) |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| " Further, while the Food and Drug Administration has pointed out that female dosing should be half that given to males, results of this population testing indicate that the majority of patients (83% male and 73% female) receive 10 mg/day or 12." | ( Zolpidem and Zolpidem Carboxylic Acid Results from Medication Monitoring. Cummings, OT; Feng, S; McIntire, G, 2018) | 0.85 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 23.90
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.90) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (12.50%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (87.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||